tiprankstipranks
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
Holding DYN?
Track your performance easily

Dyne Therapeutics (DYN) Financial Statements

294 Followers

Dyne Therapeutics Financial Overview

Dyne Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.562; its P/E ratio is -8.35; Dyne Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.93. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -105.66M$ -71.96M$ -69.16M$ -67.69M$ -62.27M
EBITDA$ -106.20M$ -71.56M$ -68.77M$ -67.29M$ -61.84M
Net Income Common Stockholders$ -97.13M$ -65.10M$ -65.65M$ -66.64M$ -60.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 723.67M$ 778.84M$ 453.55M$ 123.10M$ 157.82M
Total Assets$ 768.84M$ 825.88M$ 522.28M$ 165.08M$ 205.24M
Total Debt$ 24.86M$ 25.72M$ 26.62M$ 27.41M$ 28.23M
Net Debt$ -698.82M$ -753.12M$ -426.93M$ -95.69M$ -129.60M
Total Liabilities$ 63.30M$ 50.69M$ 44.22M$ 73.79M$ 53.21M
Stockholders Equity$ 705.54M$ 775.19M$ 478.06M$ 91.29M$ 152.04M
Cash Flow-
Free Cash Flow$ -74.88M$ -55.73M$ -78.73M$ -35.09M$ -50.77M
Operating Cash Flow$ -74.63M$ -54.87M$ -78.54M$ -35.01M$ -50.60M
Investing Cash Flow$ -19.40M$ 11.17M$ -179.84M$ 26.20M$ 12.82M
Financing Cash Flow$ 18.01M$ 379.86M$ 408.39M$ 147.00K$ 454.00K
Currency in USD

Dyne Therapeutics Earnings and Revenue History

Dyne Therapeutics Debt to Assets

Dyne Therapeutics Cash Flow

Dyne Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis